Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00320_DB05521_nanopub.RAA3src3KZmhQOwkae38M-1go8jrRT8msaBV878dtXSQ0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00320_DB05521 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00320_DB05521 label "DDI between Dihydroergotamine and Telaprevir - Telaprevir increases levels by affecting CYP3A4 metabolism. Concomitant therapy is contraindicated. [drugbank_resource:DB00320_DB05521]" assertion.
- drugbank_resource:DB00320_DB05521 identifier "drugbank_resource:DB00320_DB05521" assertion.
- drugbank_resource:DB00320_DB05521 title "DDI between Dihydroergotamine and Telaprevir - Telaprevir increases levels by affecting CYP3A4 metabolism. Concomitant therapy is contraindicated." assertion.
- drugbank:DB05521 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00320_DB05521 assertion.
- drugbank:DB00320 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00320_DB05521 assertion.